<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35292673</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Neuroprotective effects of violacein in a model of inherited amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>4439</StartPage><MedlinePgn>4439</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4439</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-06470-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive death of motor neurons and muscle atrophy, with defective neuron-glia interplay and emergence of aberrant glial phenotypes having a role in disease pathology. Here, we have studied if the pigment violacein with several reported protective/antiproliferative properties may control highly neurotoxic astrocytes (AbAs) obtained from spinal cord cultures of symptomatic hSOD1G93A rats, and if it could be neuroprotective in this ALS experimental model. At concentrations lower than those reported as protective, violacein selectively killed aberrant astrocytes. Treatment of hSOD1G93A rats with doses equivalent to the&#xa0;concentrations that killed AbAs caused a marginally significant delay in survival, partially preserved the body weight and soleus muscle mass and improved the integrity of the neuromuscular junction. Reduced motor neuron death and glial reactivity was also found and likely related to decreased inflammation and matrix metalloproteinase-2 and -9. Thus, in spite that new experimental designs aimed at extending the lifespan of hSOD1G93A rats are needed, improvements observed upon violacein treatment suggest a significant therapeutic potential that deserves further studies.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olivera-Bravo</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay. solivera@iibce.edu.uy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolatto</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Histology and Embryology Department, Faculty of Medicine, Universidad de La Rep&#xfa;blica (UdelaR), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otero Damianovich</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stancov</LastName><ForeName>Mat&#xed;as</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerri</LastName><ForeName>Sof&#xed;a</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Histology and Embryology Department, Faculty of Medicine, Universidad de La Rep&#xfa;blica (UdelaR), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boragno</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez Mir</LastName><ForeName>Karina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Histology and Embryology Department, Faculty of Medicine, Universidad de La Rep&#xfa;blica (UdelaR), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuiti&#xf1;o</LastName><ForeName>Mar&#xed;a Noel</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larrambembere</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isasi</LastName><ForeName>Eugenia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Histology and Embryology Department, Faculty of Medicine, Universidad de La Rep&#xfa;blica (UdelaR), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alem</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Genetic Department, IIBCE, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canclini</LastName><ForeName>Luc&#xed;a</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Genetic Department, IIBCE, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marco</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tumoral Biol Area, Clin Biochem Department, Faculty of Chemistry, UdelaR, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davyt</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pharm Chem Lab, Organic Chemistry Department, Faculty of Chemistry, UdelaR, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az-Amarilla</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cell and Mol Neurobiol Lab, NCIC Department, Instituto de Investigaciones Biol&#xf3;gicas Clemente Estable (IIBCE), Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007211">Indoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.24</RegistryNumber><NameOfSubstance UI="D020778">Matrix Metalloproteinase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>QJH0DSQ3SG</RegistryNumber><NameOfSubstance UI="C063155">violacein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020778" MajorTopicYN="N">Matrix Metalloproteinase 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="Y">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>5</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35292673</ArticleId><ArticleId IdType="pmc">PMC8924276</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-06470-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-06470-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001;2:806&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Chalabi A, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry. 2010;81:1324&#x2013;1326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva, H. &amp; Maragakis, N. J. Motoneuron disease: Clinical (ed. Beart, P., Robinson, M., Rattray, M. &amp; Maragakis, N.) 191&#x2013;210 (Springer, 2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28674982</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland DS, et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant mediated amyotrophic lateral sclerosis (ALS) Proc. Natl. Acad. Sci. U. S. A. 2002;99:1604&#x2013;1609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122237</ArticleId><ArticleId IdType="pubmed">11818550</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Vandevelde C, Cleveland DW. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell. Biol. 2009;187:761&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011;29:824&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Re DB, et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81:1001&#x2013;1008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Amarilla P, et al. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2011;108:18126&#x2013;18131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Das MM, Svendsen CN. Astrocytes show reduced support of motor neurons with aging that is accelerated in a rodent model of ALS. Neurobiol. Aging. 2015;36:1130&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pubmed">25443290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibarburu S, et al. Focal transplantation of aberrant glial cells carrying the SOD1G93A mutation into rat spinal cord induces extensive gliosis. Neuroimmunomodulation. 2017;24:143&#x2013;153. doi: 10.1159/000480639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000480639</ArticleId><ArticleId IdType="pubmed">29131016</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Riani M, et al. Ultrastructural features of aberrant glial cells isolated from the spinal cord of paralytic rats expressing the amyotrophic lateral sclerosis-linked SOD1G93A mutation. Cell Tissue Res. 2017;370:391&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">28864831</ArticleId></ArticleIdList></Reference><Reference><Citation>Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J. Gen. Physiol. 1927;8:519&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2140820</ArticleId><ArticleId IdType="pubmed">19872213</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel E, et al. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e34776. doi: 10.1371/journal.pone.0034776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034776</ArticleId><ArticleId IdType="pmc">PMC3318006</ArticleId><ArticleId IdType="pubmed">22509356</ArticleId></ArticleIdList></Reference><Reference><Citation>Alem D, et al. Production and antiproliferative effect of violacein, a purple pigment produced by an Antarctic bacterial isolate. World J. Microbiol. Biotechnol. 2020;36:120. doi: 10.1007/s11274-020-02893-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11274-020-02893-4</ArticleId><ArticleId IdType="pubmed">32681377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira CV, et al. Molecular mechanism of violacein-mediated human leukemia cell death. Blood. 2004;104:1459&#x2013;1464.</Citation><ArticleIdList><ArticleId IdType="pubmed">15130948</ArticleId></ArticleIdList></Reference><Reference><Citation>Konzen M, et al. Antioxidant properties of violacein: Possible relation on its biological function. Bioorg. Med. Chem. 2006;14:8307&#x2013;8313.</Citation><ArticleIdList><ArticleId IdType="pubmed">17011197</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal AMS, et al. Violacein induces cell death by triggering mitochondrial membrane hyperpolarization in vitro. BMC Microbiol. 2015;15:115. doi: 10.1186/s12866-015-0452-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-015-0452-2</ArticleId><ArticleId IdType="pmc">PMC4457087</ArticleId><ArticleId IdType="pubmed">26048053</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuelli L, et al. Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo. Tumor Biol. 2016;37:3705&#x2013;3717.</Citation><ArticleIdList><ArticleId IdType="pubmed">26462840</ArticleId></ArticleIdList></Reference><Reference><Citation>Venegas FA, et al. The bacterial product violacein exerts an immunostimulatory effect via TLR8. Sci. Rep. 2019;9:13661. doi: 10.1038/s41598-019-50038-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-50038-x</ArticleId><ArticleId IdType="pmc">PMC6754391</ArticleId><ArticleId IdType="pubmed">31541142</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho DD, Costa FT, Duran N, Haun M. Cytotoxic activity of violacein in human colon cancer cells. Toxicol. In Vitro. 2006;20:1514&#x2013;1521.</Citation><ArticleIdList><ArticleId IdType="pubmed">16889929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodach LL, et al. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. Carcinogenesis. 2006;27:508&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">16344270</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromberg N, et al. Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor. Chem. Biol. Interact. 2010;186:43&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">20416285</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshatwi AA, Subash-Babu P, Antonisamy P. Violacein induces apoptosis in human breast cancer cells through up regulation of BAX, p53 and down regulation of MDM2. Exp. Toxicol. Pathol. 2016;68:89&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">26521020</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SY, Yoon KI, Lee J, Mitchell RJ. Violacein: Properties and production of a versatile bacterial pigment. Biomed. Res. Int. 2015;2015:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4538413</ArticleId><ArticleId IdType="pubmed">26339614</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz KCS, et al. Violacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapse. PLoS ONE. 2012;7:e45362. doi: 10.1371/journal.pone.0045362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045362</ArticleId><ArticleId IdType="pmc">PMC3469566</ArticleId><ArticleId IdType="pubmed">23071514</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonisamy P, Ignacimuthu S. Immunomodulatory, analgesic and antipyretic effects of violacein isolated from Chromobacterium violaceum. Phytomedicine. 2010;17:300&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">19576742</ArticleId></ArticleIdList></Reference><Reference><Citation>Verinaud L, et al. Violacein treatment modulates acute and chronic inflammation through the suppression of cytokine production and induction of regulatory T cells. PLoS ONE. 2015;10:e0125409. doi: 10.1371/journal.pone.0125409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0125409</ArticleId><ArticleId IdType="pmc">PMC4418714</ArticleId><ArticleId IdType="pubmed">25938431</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt D, et al. Violacein inhibits matrix metalloproteinase mediated CXCR4 expression: Potential anti-tumor effect in cancer invasion and metastasis. Biochem. Biophys. Res. Commun. 2014;455:107&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4293260</ArticleId><ArticleId IdType="pubmed">25450700</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L, et al. MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. J. Neurol. Sci. 2010;294:51&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">20441996</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A, et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron. 2014;81:333&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A, Nedergaard M. Physiology of astroglia. Physiol. Rev. 2018;98:239&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050349</ArticleId><ArticleId IdType="pubmed">29351512</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivera S, et al. Astrocytic proliferation and mitochondrial dysfunction induced by accumulated glutaric acidemia I (GAI) metabolites: Possible implications for GAI pathogenesis. Neurobiol. Dis. 2008;32:528&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">18930146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmer DB, Van Eldik LJ. Levels and distribution of the calcium-modulated proteins S100 and calmodulin in rat C6 glioma cells. J. Neurochem. 1988;50:572&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">3275741</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterhouse RN. Determination of lipophilicity and its use as a predictor of blood brain barrier penetration of molecular imaging agents. Mol. Imaging Biol. 2004;5:376&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">14667492</ArticleId></ArticleIdList></Reference><Reference><Citation>Buschmann J. The OECD guidelines for the testing of chemicals and pesticides. Methods Mol. Biol. 2013;947:37&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">23138894</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes T, et al. Analysis of the applicability and use of Lipinski&#x2019;s rule for central nervous system drugs. Lett. Drug Des. Discov. 2006;13:999&#x2013;1006.</Citation></Reference><Reference><Citation>Olivera-Bravo S, et al. Neonatal astrocyte damage is sufficient to trigger progressive striatal degeneration in a rat model of glutaric White matter injury induced by perinatal exposure to glutaric acid. PLoS ONE. 2011;6:e20831. doi: 10.1371/journal.pone.0020831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020831</ArticleId><ArticleId IdType="pmc">PMC3115973</ArticleId><ArticleId IdType="pubmed">21698251</ArticleId></ArticleIdList></Reference><Reference><Citation>Dienel GA. The metabolic trinity, glucose-glycogen-lactate, links astrocytes and neurons in brain energetics, signaling, memory, and gene expression. Neurosci. Lett. 2017;637:18&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">25725168</ArticleId></ArticleIdList></Reference><Reference><Citation>Yellen G. Fueling thought: Management of glycolysis and oxidative phosphorylation in neuronal metabolism. J. Cell. Biol. 2018;217:2235&#x2013;2246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6028533</ArticleId><ArticleId IdType="pubmed">29752396</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S, Noack H, Possel H, Keilhoff G, Wolf G. Glutathione levels in primary glial cultures: Monochlorobimane provides evidence of cell type-specific distribution. Glia. 1999;27:152&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">10417814</ArticleId></ArticleIdList></Reference><Reference><Citation>Marco M, et al. Gelatinases as markers of chronic alcohol consum. An. F. Med. 2020;7:e2020v7n1a3. doi: 10.25184/anfamed2020v7n1a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.25184/anfamed2020v7n1a3</ArticleId></ArticleIdList></Reference><Reference><Citation>Isasi E, Barbeito L, Olivera-Bravo S. Increased blood-brain barrier permeability and alterations in perivascular astrocytes and pericytes induced by intracisternal glutaric acid. Fluids Barriers CNS. 2014;11:15. doi: 10.1186/2045-8118-11-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-11-15</ArticleId><ArticleId IdType="pmc">PMC4115159</ArticleId><ArticleId IdType="pubmed">25077029</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvarna, S. K., Layton, C. &amp; Bancroft, J. D. Theory and Practice of Histological Techniques, 5th edition (ed. Bancroft, J. D. &amp; Gamble, M.) (Elsevier, 2013).</Citation></Reference><Reference><Citation>Bolatto C, Olivera-Bravo S, Cerri S. Dissection of single skeletal muscle fibers for immunofluorescent and morphometric analyses of whole-mount neuromuscular junctions. J. Vis Exp. 2021;14:174. doi: 10.3791/626202021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/626202021</ArticleId><ArticleId IdType="pubmed">34459813</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMario JX. KLF10 gene expression modulates fibrosis in dystrophic skeletal muscle. Am. J. Pathol. 2018;188:1263&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pubmed">29458012</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang YM, Chiong F, Kuznetsov D, Kasarskis E, Geula C. Motor neurons are rich in non-phosphorylated neurofilaments: Cross-species comparison and alterations in ALS. Brain Res. 2000;861:45&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">10751564</ArticleId></ArticleIdList></Reference><Reference><Citation>Isasi E, Korte N, Abudara V, Attwell D, Olivera-Bravo S. Glutaric acid affects pericyte contractility and migration: Possible implications for GA-I pathogenesis. Mol. Neurobiol. 2019;56:7694&#x2013;7707.</Citation><ArticleIdList><ArticleId IdType="pubmed">31104295</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, et al. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J. Neuroinflammation. 2017;13:177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4940876</ArticleId><ArticleId IdType="pubmed">27400786</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez D, et al. ALS skeletal muscle shows enhanced TGF-&#x3b2; signaling, fibrosis and induction of fibro/adipogenic progenitor markers. PLoS ONE. 2017;12:e0177649&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5433732</ArticleId><ArticleId IdType="pubmed">28520806</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S, D'Ambrosi N. Fibrosis as a common trait in amyotrophic lateral sclerosis tissues. Neural Regen. Res. 2022;17:97&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8451558</ArticleId><ArticleId IdType="pubmed">34100438</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahdy MAA. Skeletal muscle fibrosis: An overview. Cell Tissue Res. 2019;375:575&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">30421315</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupois LL, Echaniz-Laguna A. Skeletal muscle in motor neuron diseases: Therapeutic target and delivery route for potential treatments. Curr. Drug Targets. 2010;11:1250&#x2013;1261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4834127</ArticleId><ArticleId IdType="pubmed">20840067</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher LR, et al. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau &#xc9;, Di Polo A, Vande Velde C, Robitaille R. Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS. Elife. 2018;7:e41973. doi: 10.7554/eLife.41973.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.41973</ArticleId><ArticleId IdType="pmc">PMC6234026</ArticleId><ArticleId IdType="pubmed">30320556</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I, Janik P, Soko&#x142;owska B, Kwiecinski H. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur. J. Neurol. 2010;17:226&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">19796283</ArticleId></ArticleIdList></Reference><Reference><Citation>Olmos G, Llado J. Tumor necrosis factor alpha: A link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014;2014:861231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4055424</ArticleId><ArticleId IdType="pubmed">24966471</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F, Molawi K, Zychlinsky A. Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 2010;107:13046&#x2013;13050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Ehrhart J, Sanberg PR, Borlongan CV. Potential role of humoral IL-6 cytokine in mediating pro-inflammatory endothelial cell response in amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2018;19:4232018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5855645</ArticleId><ArticleId IdType="pubmed">29385088</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>